Introduction: Penile cancer is a rare malignant neoplasm, yet it carries significant consequences, particularly in the Northern and Northeastern regions of Brazil, where it accounts for 10% of male cancers. Closely associated with poverty, poor hygiene practices, and low educational levels, this disease tends to progress aggressively and is often diagnosed at advanced stages. Studying the epidemiological profile in the state of Pará is essential to guide preventive strategies and promote early diagnosis among vulnerable populations. Objectives: To analyze the epidemiological profile of penile cancer cases in the municipalities of Belém and Ananindeua between 2015 and 2019. Methods: This is a descriptive, retrospective, and ecological epidemiological study based on secondary data. Penile cancer cases reported in Belém and Ananindeua between 2015 and 2019 were evaluated using data from the Population-Based Cancer Registry(RCBP, as per its Portuguese acronym). The variables analyzed included age-standardized incidence rates by primary site and the age distribution of cases. Data were organized and examined quantitatively. As public data were utilized, the study was exempt from review by a Research Ethics Committee, in accordance with Resolution 466/2012 of the Brazilian National Health Council. Results: Between 2015 and 2019, a total of 81 cases of penile cancer were registered in Belém and Ananindeua, according to RCBP data. The overall incidence rate was 1.72 per 100,000 men, with an age-standardized incidence rate of 2.13 per 100,000, indicating a high incidence after age adjustment. The age distribution showed a higher proportion of cases among men aged 70 years and older, especially in the age groups 75–79 (16.83 per 100,000), 80–84 (18.79 per 100,000), and 85+ (21.65 per 100,000). Younger men showed negligible or no incidence. From the age of 50 onwards, a continuous increase in incidence was observed. The findings reveal a cumulative pattern associated with aging, highlighting the need for improved prevention and early detection strategies targeting elderly men in the region. Conclusion: The data indicate that penile cancer constitutes a public health concern in Belém and Ananindeua, with the highest incidence observed among elderly men. The concentration of cases in those aged 70 years and older underscores the importance of preventive, educational, and early detection measures focused on men with greater vulnerability.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
